Paliperidone Teva 50 mg inj. susp. prol.-rel. i.m. pre-filled syr. Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

paliperidone teva 50 mg inj. susp. prol.-rel. i.m. pre-filled syr.

teva pharma belgium sa-nv - paliperidone palmitate 156 mg/ml - eq. paliperidone 100 mg/ml - prolonged-release suspension for injection - 50 mg - paliperidone palmitate 156 mg/ml - paliperidone

Paliperidone Teva 25 mg inj. susp. prol.-rel. i.m. pre-filled syr. Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

paliperidone teva 25 mg inj. susp. prol.-rel. i.m. pre-filled syr.

teva pharma belgium sa-nv - paliperidone palmitate 156 mg/ml - eq. paliperidone 100 mg/ml - prolonged-release suspension for injection - 25 mg - paliperidone palmitate 156 mg/ml - paliperidone

Paliperidone Teva 75 mg inj. susp. prol.-rel. i.m. pre-filled syr. Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

paliperidone teva 75 mg inj. susp. prol.-rel. i.m. pre-filled syr.

teva pharma belgium sa-nv - paliperidone palmitate 156 mg/ml - eq. paliperidone 100 mg/ml - prolonged-release suspension for injection - 75 mg - paliperidone palmitate 156 mg/ml - paliperidone

Paliperidone Teva 100 mg inj. susp. prol.-rel. i.m. pre-filled syr. Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

paliperidone teva 100 mg inj. susp. prol.-rel. i.m. pre-filled syr.

teva pharma belgium sa-nv - paliperidone palmitate 156 mg/ml - eq. paliperidone 100 mg/ml - prolonged-release suspension for injection - 100 mg - paliperidone palmitate 156 mg/ml - paliperidone

Paliperidone Teva 150 mg inj. susp. prol.-rel. i.m. pre-filled syr. Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

paliperidone teva 150 mg inj. susp. prol.-rel. i.m. pre-filled syr.

teva pharma belgium sa-nv - paliperidone palmitate 156 mg/ml - eq. paliperidone 100 mg/ml - prolonged-release suspension for injection - 150 mg - paliperidone palmitate 156 mg/ml - paliperidone

INVEGA 3 MG Izrael - angličtina - Ministry of Health

invega 3 mg

j-c health care ltd - paliperidone - tablets extended release - paliperidone 3 mg - paliperidone - paliperidone - invega is indicated for :-treatment of schizophrenia in adults and adolescents (12-17 years).-treatment of schizoaffective disorder in adults.

INVEGA 6 MG Izrael - angličtina - Ministry of Health

invega 6 mg

j-c health care ltd - paliperidone - tablets extended release - paliperidone 6 mg - paliperidone - paliperidone - invega is indicated for :-treatment of schizophrenia in adults and adolescents (12-17 years).-treatment of schizoaffective disorder in adults.

INVEGA 9 MG Izrael - angličtina - Ministry of Health

invega 9 mg

j-c health care ltd - paliperidone - tablets extended release - paliperidone 9 mg - paliperidone - paliperidone - invega is indicated for :-treatment of schizophrenia in adults and adolescents (12-17 years).-treatment of schizoaffective disorder in adults.

INVEGA SUSTENNA paliperidone (as palmitate) 100 mg modified release suspension for injection pre-filled syringe Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

invega sustenna paliperidone (as palmitate) 100 mg modified release suspension for injection pre-filled syringe

janssen-cilag pty ltd - paliperidone palmitate, quantity: 156 mg (equivalent: paliperidone, qty 100 mg) - injection - excipient ingredients: dibasic sodium phosphate; water for injections; macrogol 4000; monobasic sodium phosphate monohydrate; polysorbate 20; citric acid monohydrate; sodium hydroxide - invega sustenna is indicated for the acute and maintenance treatment of schizophrenia in adults.

INVEGA SUSTENNA paliperidone (as palmitate) 75 mg modified release suspension for injection pre-filled syringe Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

invega sustenna paliperidone (as palmitate) 75 mg modified release suspension for injection pre-filled syringe

janssen-cilag pty ltd - paliperidone palmitate, quantity: 117 mg (equivalent: paliperidone, qty 75 mg) - injection - excipient ingredients: sodium hydroxide; polysorbate 20; macrogol 4000; water for injections; dibasic sodium phosphate; monobasic sodium phosphate monohydrate; citric acid monohydrate - invega sustenna is indicated for the acute and maintenance treatment of schizophrenia in adults.